Naloxegol | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Naloxegol
US Patents

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Naloxegol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 3 USDMF, 1 EU WC, 5 NDC API, 1 Listed Suppliers, $ API Reference Price

4 API Suppliers
3 USDMF
1 EU WC
5 NDC API
1 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

17 FDF Dossiers, 4 FDA Orange Book, 11 Europe, 2 Canada

17 FDF Dossiers
4 FDA Orange Book
11 Europe
2 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12.5MG BASE, TABLET;ORAL - EQ 25MG BASE

TABLET;ORAL - EQ 12.5MG BASE
TABLET;ORAL - EQ 25MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 23 Direct Compression, 20 Controlled & Modified Release, 15 Disintegrants & Superdisintegrants, 13 Thickeners and Stabilizers, 12 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 12 Granulation, 12 Taste Masking, 10 Lubricants & Glidants, 8 Film Formers & Plasticizers, 6 API Stability Enhancers, 5 Parenteral, 5 Empty Capsules, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 2 Emulsifying Agents, 2 Topical, 1 Solubilizers, 1 Surfactant & Foaming Agents

44 Coating Systems & Additives
42 Fillers, Diluents & Binders
23 Direct Compression
20 Controlled & Modified Release
15 Disintegrants & Superdisintegrants
13 Thickeners and Stabilizers
12 Chewable & Orodispersible Aids
12 Co-Processed Excipients
12 Granulation
12 Taste Masking
10 Lubricants & Glidants
8 Film Formers & Plasticizers
6 API Stability Enhancers
5 Parenteral
5 Empty Capsules
5 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
2 Emulsifying Agents
2 Topical
1 Solubilizers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Finished Drug Prices, 14 Annual Reports

1 US Medicaid Prescriptions
9 Finished Drug Prices
14 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

8 US Patents, 6 Health Canada Patents

8 US Patents
6 Health Canada Patents

$ API Ref.Price (USD/KG) : 48,251 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8VALINOR

filter Patent Number Reset all filters

8 All

01 27056500

02 27786133

03 28067431

04 29012469

filter API Patent Reset all filters

8 All

01 4Y

02 4Blank

filter FDF Patent Reset all filters

8 All

01 6Y

02 2Blank

filter Expiration Date Reset all filters

8 All

01 22024-06-29

02 22024-12-16

03 22028-09-16

04 22032-04-02

Product Main Page

01

VALINOR

NALOXEGOL OXALATE

Compamed

Not Confirmed

VALINOR

Country

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-12-16

NALOXEGOL OXALATE

US Patent Number : 8067431

Drug Substance Claim :

Drug Product Claim :

Application Number : 204760

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2024-12-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

VALINOR

NALOXEGOL OXALATE

Compamed

Not Confirmed

VALINOR

Country

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-12-16

NALOXEGOL OXALATE

US Patent Number : 8067431

Drug Substance Claim :

Drug Product Claim :

Application Number : 204760

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2024-12-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

VALINOR

NALOXEGOL OXALATE

Compamed

Not Confirmed

VALINOR

Country

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-06-29

NALOXEGOL OXALATE

US Patent Number : 7056500

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204760

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2024-06-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

VALINOR

NALOXEGOL OXALATE

Compamed

Not Confirmed

VALINOR

Country

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-06-29

NALOXEGOL OXALATE

US Patent Number : 7056500

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204760

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2024-06-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

VALINOR

NALOXEGOL OXALATE

Compamed

Not Confirmed

VALINOR

Country

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-09-16

NALOXEGOL OXALATE

US Patent Number : 7786133

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-09-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

VALINOR

NALOXEGOL OXALATE

Compamed

Not Confirmed

VALINOR

Country

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-04-02

NALOXEGOL OXALATE

US Patent Number : 9012469

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

VALINOR

NALOXEGOL OXALATE

Compamed

Not Confirmed

VALINOR

Country

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-04-02

NALOXEGOL OXALATE

US Patent Number : 9012469

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

VALINOR

NALOXEGOL OXALATE

Compamed

Not Confirmed

VALINOR

Country

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-09-16

NALOXEGOL OXALATE

US Patent Number : 7786133

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-09-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?